nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—obesity—polycystic ovary syndrome	0.67	1	CtDrD
Benzphetamine—ADRA1A—polycystic ovary syndrome	0.28	1	CbGaD
Benzphetamine—CYP3A4—urine—polycystic ovary syndrome	0.000958	0.0692	CbGeAlD
Benzphetamine—POR—adrenal cortex—polycystic ovary syndrome	0.000784	0.0566	CbGeAlD
Benzphetamine—POR—endometrium—polycystic ovary syndrome	0.0007	0.0506	CbGeAlD
Benzphetamine—SLC18A2—endometrium—polycystic ovary syndrome	0.000667	0.0482	CbGeAlD
Benzphetamine—POR—pituitary gland—polycystic ovary syndrome	0.000634	0.0457	CbGeAlD
Benzphetamine—POR—adipose tissue—polycystic ovary syndrome	0.000631	0.0456	CbGeAlD
Benzphetamine—SLC18A2—uterus—polycystic ovary syndrome	0.000615	0.0444	CbGeAlD
Benzphetamine—SLC18A2—adipose tissue—polycystic ovary syndrome	0.000601	0.0434	CbGeAlD
Benzphetamine—POR—adrenal gland—polycystic ovary syndrome	0.000566	0.0409	CbGeAlD
Benzphetamine—SLC18A2—adrenal gland—polycystic ovary syndrome	0.000539	0.039	CbGeAlD
Benzphetamine—POR—female gonad—polycystic ovary syndrome	0.000528	0.0381	CbGeAlD
Benzphetamine—POR—vagina—polycystic ovary syndrome	0.000525	0.0379	CbGeAlD
Benzphetamine—SLC18A2—vagina—polycystic ovary syndrome	0.0005	0.0361	CbGeAlD
Benzphetamine—POR—endocrine gland—polycystic ovary syndrome	0.000491	0.0354	CbGeAlD
Benzphetamine—SLC18A2—endocrine gland—polycystic ovary syndrome	0.000468	0.0338	CbGeAlD
Benzphetamine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000341	0.0246	CbGeAlD
Benzphetamine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000336	0.0243	CbGeAlD
Benzphetamine—SLC6A2—adrenal gland—polycystic ovary syndrome	0.000329	0.0238	CbGeAlD
Benzphetamine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000306	0.0221	CbGeAlD
Benzphetamine—ADRA2A—endometrium—polycystic ovary syndrome	0.000288	0.0208	CbGeAlD
Benzphetamine—SLC6A2—endocrine gland—polycystic ovary syndrome	0.000285	0.0206	CbGeAlD
Benzphetamine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000265	0.0192	CbGeAlD
Benzphetamine—ADRA2A—uterus—polycystic ovary syndrome	0.000265	0.0192	CbGeAlD
Benzphetamine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.00026	0.0188	CbGeAlD
Benzphetamine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000259	0.0187	CbGeAlD
Benzphetamine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000243	0.0175	CbGeAlD
Benzphetamine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000233	0.0168	CbGeAlD
Benzphetamine—Dextroamphetamine—ADRA1B—polycystic ovary syndrome	0.00023	0.107	CrCbGaD
Benzphetamine—CYP2B6—vagina—polycystic ovary syndrome	0.000225	0.0162	CbGeAlD
Benzphetamine—ADRA2A—female gonad—polycystic ovary syndrome	0.000217	0.0157	CbGeAlD
Benzphetamine—ADRA2A—vagina—polycystic ovary syndrome	0.000216	0.0156	CbGeAlD
Benzphetamine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00021	0.0152	CbGeAlD
Benzphetamine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000202	0.0146	CbGeAlD
Benzphetamine—Modafinil—ADRA1B—polycystic ovary syndrome	0.000197	0.0911	CrCbGaD
Benzphetamine—Phenoxybenzamine—ADRA1D—polycystic ovary syndrome	0.000191	0.0885	CrCbGaD
Benzphetamine—Phenoxybenzamine—ADRA1B—polycystic ovary syndrome	0.000163	0.0755	CrCbGaD
Benzphetamine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000159	0.0115	CbGeAlD
Benzphetamine—Dextroamphetamine—ADRA1A—polycystic ovary syndrome	0.000155	0.0718	CrCbGaD
Benzphetamine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000139	0.0645	CrCbGaD
Benzphetamine—Promazine—ADRA1D—polycystic ovary syndrome	0.000138	0.064	CrCbGaD
Benzphetamine—Promazine—ADRA1B—polycystic ovary syndrome	0.000118	0.0546	CrCbGaD
Benzphetamine—Toremifene—CYP1A1—polycystic ovary syndrome	0.000114	0.053	CrCbGaD
Benzphetamine—Phenoxybenzamine—ADRA1A—polycystic ovary syndrome	0.00011	0.0508	CrCbGaD
Benzphetamine—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.000105	0.0487	CrCbGaD
Benzphetamine—Trimipramine—ADRA1A—polycystic ovary syndrome	9.36e-05	0.0434	CrCbGaD
Benzphetamine—Promethazine—ADRA1A—polycystic ovary syndrome	9.02e-05	0.0418	CrCbGaD
Benzphetamine—Promazine—ADRA1A—polycystic ovary syndrome	7.93e-05	0.0368	CrCbGaD
Benzphetamine—Phenoxybenzamine—ADRB2—polycystic ovary syndrome	6.52e-05	0.0302	CrCbGaD
Benzphetamine—Tamoxifen—CYP19A1—polycystic ovary syndrome	6.21e-05	0.0288	CrCbGaD
Benzphetamine—Methadone—CYP19A1—polycystic ovary syndrome	6.15e-05	0.0285	CrCbGaD
Benzphetamine—Tamoxifen—CYP1A1—polycystic ovary syndrome	4.57e-05	0.0212	CrCbGaD
Benzphetamine—ADRA2A—Metabolism—AKR1C2—polycystic ovary syndrome	1.8e-05	0.000529	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.79e-05	0.000528	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	1.79e-05	0.000527	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	1.79e-05	0.000526	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	1.77e-05	0.000521	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	1.73e-05	0.000509	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	1.73e-05	0.000509	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—PLAT—polycystic ovary syndrome	1.72e-05	0.000506	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—FSHR—polycystic ovary syndrome	1.72e-05	0.000505	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	1.71e-05	0.000504	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	1.69e-05	0.000497	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TEAD2—polycystic ovary syndrome	1.69e-05	0.000496	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKR1C2—polycystic ovary syndrome	1.69e-05	0.000496	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	1.67e-05	0.00049	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NPB—polycystic ovary syndrome	1.66e-05	0.000489	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	1.66e-05	0.000488	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	1.66e-05	0.000488	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	1.66e-05	0.000487	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—LHB—polycystic ovary syndrome	1.65e-05	0.000484	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—POMC—polycystic ovary syndrome	1.64e-05	0.000483	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	1.63e-05	0.000479	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	1.62e-05	0.000476	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	1.61e-05	0.000473	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	1.61e-05	0.000473	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	1.59e-05	0.000468	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.59e-05	0.000468	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	1.59e-05	0.000467	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	1.58e-05	0.000466	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	1.57e-05	0.000463	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	1.57e-05	0.000463	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	1.57e-05	0.000462	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—SCT—polycystic ovary syndrome	1.54e-05	0.000454	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	1.51e-05	0.000445	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	1.51e-05	0.000443	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PNPLA2—polycystic ovary syndrome	1.51e-05	0.000443	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	1.5e-05	0.000442	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—LHB—polycystic ovary syndrome	1.49e-05	0.00044	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	1.49e-05	0.000439	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	1.49e-05	0.000439	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	1.49e-05	0.000439	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—GNAS—polycystic ovary syndrome	1.48e-05	0.000434	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	1.47e-05	0.000433	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	1.47e-05	0.000433	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	1.46e-05	0.00043	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	1.44e-05	0.000423	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SRD5A1—polycystic ovary syndrome	1.43e-05	0.00042	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PNPLA2—polycystic ovary syndrome	1.41e-05	0.000415	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	1.4e-05	0.000413	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—SCT—polycystic ovary syndrome	1.4e-05	0.000412	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	1.4e-05	0.000411	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTGER3—polycystic ovary syndrome	1.39e-05	0.000408	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LHCGR—polycystic ovary syndrome	1.39e-05	0.000408	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—STAR—polycystic ovary syndrome	1.36e-05	0.000401	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	1.36e-05	0.000399	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	1.34e-05	0.000394	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	1.34e-05	0.000393	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—GNAS—polycystic ovary syndrome	1.32e-05	0.000388	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	1.32e-05	0.000388	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	1.31e-05	0.000384	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	1.3e-05	0.000382	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	1.28e-05	0.000378	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	1.28e-05	0.000376	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	1.26e-05	0.00037	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	1.23e-05	0.00036	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	1.21e-05	0.000357	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.2e-05	0.000354	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.2e-05	0.000353	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	1.19e-05	0.000351	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.19e-05	0.000349	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	1.17e-05	0.000344	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	1.16e-05	0.000341	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	1.14e-05	0.000335	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	1.11e-05	0.000328	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	1.09e-05	0.000321	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	1.09e-05	0.00032	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	1.09e-05	0.000319	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.08e-05	0.000319	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	1.07e-05	0.000315	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	1.06e-05	0.000312	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.06e-05	0.000312	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	1.06e-05	0.000311	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	1.03e-05	0.000304	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	1.03e-05	0.000302	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	1.02e-05	0.000299	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	1e-05	0.000294	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	9.94e-06	0.000292	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	9.9e-06	0.000291	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	9.87e-06	0.00029	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	9.74e-06	0.000286	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.69e-06	0.000285	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.69e-06	0.000285	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	9.68e-06	0.000285	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	9.68e-06	0.000285	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	9.62e-06	0.000283	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	9.54e-06	0.000281	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	9.5e-06	0.00028	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	9.37e-06	0.000276	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	9.29e-06	0.000273	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	9.28e-06	0.000273	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	9.2e-06	0.000271	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	9.05e-06	0.000266	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	9.01e-06	0.000265	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	9e-06	0.000265	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	9e-06	0.000265	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	8.98e-06	0.000264	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.98e-06	0.000264	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	8.94e-06	0.000263	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	8.91e-06	0.000262	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	8.91e-06	0.000262	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	8.83e-06	0.00026	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	8.79e-06	0.000259	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	8.63e-06	0.000254	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	8.63e-06	0.000254	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	8.59e-06	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	8.55e-06	0.000251	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	8.54e-06	0.000251	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	8.5e-06	0.00025	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	8.36e-06	0.000246	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	8.35e-06	0.000246	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	8.35e-06	0.000246	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	8.34e-06	0.000245	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	8.28e-06	0.000244	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	8.28e-06	0.000243	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	8.25e-06	0.000243	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	8.24e-06	0.000242	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	8.17e-06	0.00024	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	8.15e-06	0.00024	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	8.15e-06	0.00024	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	8.12e-06	0.000239	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	8.05e-06	0.000237	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.89e-06	0.000232	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	7.76e-06	0.000228	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	7.74e-06	0.000228	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	7.73e-06	0.000227	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	7.7e-06	0.000226	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	7.69e-06	0.000226	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.66e-06	0.000225	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.66e-06	0.000225	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	7.64e-06	0.000225	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	7.62e-06	0.000224	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	7.58e-06	0.000223	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.58e-06	0.000223	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	7.29e-06	0.000214	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	7.22e-06	0.000212	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	7.18e-06	0.000211	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	7.1e-06	0.000209	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	7.08e-06	0.000208	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.93e-06	0.000204	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.82e-06	0.000201	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	6.77e-06	0.000199	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	6.75e-06	0.000199	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—TH—polycystic ovary syndrome	6.56e-06	0.000193	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.44e-06	0.000189	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.42e-06	0.000189	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	6.38e-06	0.000188	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6.34e-06	0.000186	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	6.28e-06	0.000185	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	6.28e-06	0.000185	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	6.27e-06	0.000184	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	6.15e-06	0.000181	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.08e-06	0.000179	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	6.05e-06	0.000178	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	6e-06	0.000176	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.99e-06	0.000176	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	5.98e-06	0.000176	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.84e-06	0.000172	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	5.83e-06	0.000171	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	5.83e-06	0.000171	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.81e-06	0.000171	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.8e-06	0.000171	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	5.62e-06	0.000165	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.62e-06	0.000165	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	5.58e-06	0.000164	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	5.56e-06	0.000164	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.52e-06	0.000162	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.49e-06	0.000161	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	5.48e-06	0.000161	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.42e-06	0.00016	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.4e-06	0.000159	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	5.35e-06	0.000157	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	5.28e-06	0.000155	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.19e-06	0.000153	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.17e-06	0.000152	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	5.13e-06	0.000151	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	5.1e-06	0.00015	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	5.1e-06	0.00015	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	5.09e-06	0.00015	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	5.02e-06	0.000148	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.93e-06	0.000145	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.9e-06	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	4.83e-06	0.000142	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.83e-06	0.000142	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.82e-06	0.000142	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	4.78e-06	0.000141	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.59e-06	0.000135	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	4.53e-06	0.000133	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	4.51e-06	0.000133	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.5e-06	0.000132	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.5e-06	0.000132	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.48e-06	0.000132	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.4e-06	0.000129	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.26e-06	0.000125	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.26e-06	0.000125	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	4.22e-06	0.000124	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.18e-06	0.000123	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.92e-06	0.000115	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.86e-06	0.000113	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.8e-06	0.000112	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.77e-06	0.000111	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.66e-06	0.000108	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	3.65e-06	0.000107	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	3.6e-06	0.000106	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.58e-06	0.000105	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	3.58e-06	0.000105	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.52e-06	0.000103	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.51e-06	0.000103	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.47e-06	0.000102	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	3.43e-06	0.000101	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	3.38e-06	9.94e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.37e-06	9.9e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	3.36e-06	9.88e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.28e-06	9.64e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.24e-06	9.54e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.23e-06	9.49e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	3.22e-06	9.49e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.13e-06	9.2e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.12e-06	9.17e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.12e-06	9.17e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	3.01e-06	8.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	3e-06	8.81e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.96e-06	8.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.9e-06	8.52e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.9e-06	8.52e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.79e-06	8.21e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.75e-06	8.1e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.72e-06	7.99e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.55e-06	7.51e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.39e-06	7.02e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.28e-06	6.71e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.22e-06	6.52e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.17e-06	6.39e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.06e-06	6.06e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.04e-06	5.99e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.92e-06	5.65e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.89e-06	5.57e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.56e-06	4.58e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.54e-06	4.52e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.53e-06	4.49e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.41e-06	4.14e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.31e-06	3.85e-05	CbGpPWpGaD
